United States

Select Product:

SureQuick Syphilis

Detection of TP Antibodies to aid in the diagnosis of Syphilis.

This test is suitable for testing and screening in clinical and non-clinical settings using whole blood (from venipuncture or fingerstick), serum, or plasma specimens. This valuable diagnostic tool extends to outreach programs and community health settings, enabling broader reach, beyond the conventional clinical landscape. CE marked as an in vitro diagnostic device.

Key Product Features:

Easy-to-Use
• Simple procedure format1. specimen sample
2. Add buffer
3. Wait for result
• Rapid results within 5 minutes
• Detects TP antibodies in whole blood(both fingerstick and venipuncture), serum, or plasma.
• Ambient storage and transport conditions: 2°C - 30°C (36°F - 86°F).

Accurate & Reliable
• Over 99.8% accurate:◦ Sensitivity: 99.9%
◦ Specificity: 99.7%
• Includes a control line to confirm the validity of the test.
• Shelf life of 24 months from the date of manufacture
• Utilizes recombinant Syphilis antigen and a double antigen test format to detect both IgG and IgM antibodies.

Accessible
• Competitively priced for large-scale programs.
• Short lead times

Downloadable Information

Prevalence & Trends

Multiple clinical stages and long periods of latent, asymptomatic infection are characteristic of Syphilis. Syphilis is a preventable and curable, bacterial, sexually transmitted infection (STI). If untreated, it can cause serious health issues.

  • In 2020, WHO estimated that 7.1 million adults aged 15–49 acquired syphilis globally(1)
  • Most infections are asymptomatic or unrecognized.(1)
  • In 2016, the WHO adopted a strategy to reduce Syphilis by 90% by 2030, however, recent evidence suggests an increasing trend in prevalence(2)
  1. WHO 2023, Sexually transmitted infections (STIs) https://www.who.int/news-room/fact-sheets/detail/sexually-transmitted-infections-(stis)
  2. (2) Smolak, A. 2017, Trends and Predictors of Syphilis Prevalence in the General Population: Global Pooled Analyses https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5888928/

Flexible Specimens for Clinical and Non-Clinical Settings

Step 1 -
Collect Specimen & transfer to the specimen area of the casette
Step 2 -
Add 1 drop of buffer and set timer
Step 3 -
Read between 15 and 30 minutes
Negative
Line in the C Zone

Positive
Line in the C & T Zones

Invalid Result
1. Line only in the T zone, or
2. Neither line shows

Training

Training materials for our products are available and recommended to ensure proper utilization by healthcare professionals. These materials cover specimen handling, storage, and equipment maintenance, ensuring accurate results. Request more product information »

Product not available in all territories. Please contact us for details. Please read full instructions before use.

*OraSure provides information regarding reimbursement (including, in some instances, potentially applicable CPT, HCPCS and/or analogous state or local codes or designations) for background purposes only. It does not constitute legal advice or a recommendation regarding clinical practice. Information provided is gathered from third-party sources and is subject to change without notice. The provider has the responsibility to determine medical necessity and to submit appropriate codes and charges for care provided. Any decision regarding specific coding is at the discretion of the healthcare professional, and provision of this information does not guarantee or facilitate reimbursement. OraSure makes no guarantee that the use of this information will prevent differences of opinion or disputes with Medicare or other payers as to the correct form of billing or the amount that will be paid to providers of service. Please contact your Medicare contractor, insurance provider, other payers, reimbursement specialists and/or legal counsel for interpretation of coding, coverage and payment policies or specific billing questions or concerns. Nothing herein is intended to promote or facilitate the purchase or use of products outside of their approved or cleared indications, and appropriate use of products should be based on the healthcare professional’s medical judgment.

© OraSure Technologies Inc., 2024